BriaCell Therapeutics Corp. (BCTXL) News
Follow BriaCell Therapeutics Corp. (BCTXL) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
BCTX BCTXW BCTXZ BCTXL - BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center
BCTX BCTXW BCTXZ BCTXL - BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center
EQUITY | Sep 08, 2026, 11:30 AM UTC
L
BCTX BCTXW BCTXZ BCTXL - BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™
BCTX BCTXW BCTXZ BCTXL - BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™
EQUITY | Aug 24, 2026, 11:30 AM UTC
L
BCTX BCTXW BCTXZ BCTXL - BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer
BCTX BCTXW BCTXZ BCTXL - BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer
REGULATION | Aug 05, 2026, 11:30 AM UTC
M
BCTX Partners with Uneedle
BriaCell partners with Uneedle for scalable microneedle administration of Bria-IMT
EQUITY | Jun 25, 2026, 11:30 AM UTC